Medicine
SUPREP Bowel Prep 1.2 g/2.35 g/13.13 g per 133.1 mL oral concentrate
SUPREP Bowel Prep 1.2 g/2.35 g/13.13 g per 133.1 mL oral concentrate is a prescription medicine containing Magnesium sulfate, unspecified form, Potassium sulfate and Sodium sulfate for oral use, marketed by Azurity Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Excursions permitted between 15° to 30°C…
Key facts
- Active ingredient (INN)
- Magnesium sulfate, unspecified form, Potassium sulfate and Sodium sulfate
- Brand
- SUPREP Bowel Prep
- Strength
- 1.2 g/2.35 g/13.13 g per 133.1 mL
- Dosage form
- Oral concentrate
- Route
- Oral
- Packs
- 2 bottles
- Marketing authorisation holder
- Azurity Pharmaceuticals
- Manufacturers
- Azurity PharmaceuticalsBraintree Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Excursions permitted between 15° to 30°C (59° to 86°F). See USP controlled room temperature.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 August 2010
- Identifiers
- RxCUI 1001689, 1001690, 1120068 +2DailyMed set ID 2f5f06de-ee98-44c0-be7e-9a998d1e5c16, 50f23abd-6a66-44cb-960e-d43c16a5ae5fNDC 52268-112, 24338-177Application NDA022372
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 2 bottle, plastic in 1 carton / 133.1 mL in 1 bottle, plastic | 24338-177-01 | Azurity Pharmaceuticals | 1 April 2026 |
| 2 bottle, plastic in 1 carton / 133.1 mL in 1 bottle, plastic | 52268-112-01 | Braintree Laboratories | 5 January 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Magnesium sulfate, unspecified form, Potassium sulfate and Sodium sulfate 1.2 g/2.35 g/13.13 g per 133.1 mL oral concentrate.
Other strengths and forms of Magnesium sulfate, unspecified form, Potassium sulfate and Sodium sulfate
Clinical summary
Magnesium sulfate, unspecified form, Potassium sulfate and Sodium sulfate is a fixed-dose combination of an osmotic laxative, a calculi dissolution agent and a potassium salt. MedsAcross supplies Magnesium sulfate, unspecified form, Potassium sulfate and Sodium sulfate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Magnesium sulfate, unspecified form, Potassium sulfate and Sodium sulfateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE prescribing information (Affordable Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need SUPREP Bowel Prep 1.2 g/2.35 g/13.13 g per 133.1 mL oral concentrate for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.